Related Experiment Video
Updated: Aug 29, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
[Effectiveness of recombinant activated factor VIIA (NovoSeven) in case of severe obstetric complication with
Tomasz Bielanów1, Mariusz Sidor, Michał Maciejewski
1Szpitala Specjalistycznego im. A Falkiewicza we Wrocławiu.
Abstract:
The aim of report is to present the possibilities of applying NovoSeven in serious coagulopathy in course of various obstetrical complications. At present it is utilised in acquired coagulopathy, bleedings, traumatic cases and extensive surgical operations especially associated with DIC. We report two cases of severe complications during delivery. Both patients had a massive bleeding, severe disorders of haemostasis, which on effect were leading to DIC. In therapy a large quantity of blood products were applied. Conventional treatment with anticoagulant did not give any results. Administration of NovoSeven gave at last radical turn in course of treatment and the improvement in patient's state. In obstetrical practice NovoSeven is recommendable supplement of conventional treatment in severe coagulopathy.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management